Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference at 8:00 a.m. EDT on Monday, June 7, 2010, to review data presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented at the meeting on the oncology portfolio and address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at: or by dialing 913-312-0711, confirmation code: 1985004. A replay of the call will be available beginning at 11:00 a.m. EDT on June 7 through midnight EDT on June 21. The replay can be accessed at or by dialing 402-280-9013, confirmation code: 1985004.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases. For more information, please visit


Bristol-Myers Squibb Company
Jennifer Fron Mauer, 609-252-6579
[email protected]
John Elicker, 609-252-4611
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Oncology  Pharmaceutical